Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677

BACKGROUND: The prognosis for patients with recurrent glioblastoma remains poor. The purpose of this study was to assess the potential role of MR spectroscopy as an early indicator of response to anti-angiogenic therapy. METHODS: Thirteen patients with recurrent glioblastoma were enrolled in RTOG 06...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ratai, Eva-Maria, Zhang, Zheng, Snyder, Bradley S., Boxerman, Jerrold L., Safriel, Yair, McKinstry, Robert C., Bokstein, Felix, Gilbert, Mark R., Sorensen, A. Gregory, Barboriak, Daniel P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2013
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3688017/
https://ncbi.nlm.nih.gov/pubmed/23645534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not044
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller